← Open Payments lookup

RACHEL DAVENPORT-CAMPBELL: Open Payments

NPI 1710281399 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,742 in 88 payments from 18 companies in 2025. Trend: 2023 $1,353 · 2024 $1,614 · 2025 $1,742

Food & beverage: $1,654Education: $88
CompanyPaymentsAmount
GlaxoSmithKline, LLC.26$446
AstraZeneca Pharmaceuticals LP11$218
HARMONY BIOSCIENCES LLC8$198
Amgen Inc.5$128
Boehringer Ingelheim Pharmaceuticals, Inc.5$112
GENZYME CORPORATION5$109
Electromed, Inc.7$88
Verona Pharma, Inc.4$88
Grifols USA, LLC4$79
Insmed, Inc.3$73

Products named: NUCALA, TEZSPIRE, TRELEGY ELLIPTA, DUPIXENT, WAKIX, FASENRA, SMARTVEST, Ohtuvayre.

Industry payments across KY — which companies pay providers there.